Clinical Trials

NCT04556890 | RECRUITING | NA
54 participants

Pain and Major Depressive Disorder

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-03-01
Completion:
2027-12-31
Conditions
  • Major Depressive Disorder
  • Chronic Pain
Interventions
  • DEVICE
No Results Yet
NCT04550494 | ACTIVE_NOT_RECRUITING | PHASE2
29 participants

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-04-26
Completion:
2026-07-10
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Castration-Resistant Prostate Carcinoma
  • Clinical Stage III Gastric Cancer AJCC v8
  • Clinical Stage IV Gastric Cancer AJCC v8
  • HER2-Positive Breast Carcinoma
  • Locally Advanced Breast Carcinoma
  • Locally Advanced Gastric Carcinoma
  • Locally Advanced Malignant Solid Neoplasm
  • Locally Advanced Ovarian Carcinoma
  • Locally Advanced Pancreatic Carcinoma
  • Locally Advanced Prostate Carcinoma
  • Metastatic Breast Carcinoma
  • Metastatic Gastric Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Ovarian Carcinoma
  • Metastatic Pancreatic Carcinoma
  • Metastatic Prostate Carcinoma
  • Platinum-Sensitive Ovarian Carcinoma
  • Recurrent Breast Carcinoma
  • Recurrent Gastric Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Pancreatic Carcinoma
  • Recurrent Prostate Carcinoma
  • Stage II Pancreatic Cancer AJCC v8
  • Stage III Ovarian Cancer AJCC v8
  • Stage III Pancreatic Cancer AJCC v8
  • Stage III Prostate Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Pancreatic Cancer AJCC v8
  • Stage IV Prostate Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT04526782 | ACTIVE_NOT_RECRUITING | PHASE2
119 participants

ENCOrafenib With Binimetinib in bRAF NSCLC

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-01-19
Completion:
2025-07-16
Conditions
  • Non Small Cell Lung Cancer
  • BRAF V600E
Interventions
  • DRUG
No Results Yet
NCT04267848 | RECRUITING | PHASE3
1210 participants

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2020-06-16
Completion:
2027-01-31
Conditions
  • Lung Non-Small Cell Carcinoma
  • Lung Non-Small Cell Squamous Carcinoma
  • Lung Non-Squamous Non-Small Cell Carcinoma
  • Stage II Lung Cancer AJCC v8
  • Stage IIIA Lung Cancer AJCC v8
  • Stage IIIB Lung Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page